Wake promoting agents: Search for next generation modafinil, lessons learned: Part III
Derek Dunn, Greg Hostetler, Mohamed Iqbal, Val R. Marcy, Yin Guo Lin, Bruce Jones, Lisa D. Aimone, John Gruner, Mark A. Ator, Edward R. Bacon, Sankar Chatterjee, Derek Dunn, Greg Hostetler, Mohamed Iqbal, Val R. Marcy, Yin Guo Lin, Bruce Jones, Lisa D. Aimone, John Gruner, Mark A. Ator, Edward R. Bacon, Sankar Chatterjee, Derek Dunn, Greg Hostetler, Mohamed Iqbal, Val R. Marcy, Yin Guo Lin, Bruce Jones, Lisa D. Aimone, John Gruner, Mark A. Ator, Edward R. Bacon, Sankar Chatterjee
Index: Bioorg. Med. Chem. Lett. 22(11) , 3751-3, (2012)
Full Text: HTML
Abstract
In searching for a next generation molecule to the novel wake promoting agent modafinil (compound 1), a series of fluorene-derived wakefulness enhancing agents were developed and evaluated in rat. Extensive pharmacokinetic studies of a potent member (compound 15) of the series revealed that the wake promotion activity of the analog was likely due to an active metabolite (compound 3).
Related Compounds
Related Articles:
2010-02-11
[J. Med. Chem. 53 , 1172-89, (2010)]
2015-07-07
[Analyst 140 , 4662-7, (2015)]
2016-01-15
[Clin. Chim. Acta 452 , 204-13, (2015)]
2001-12-01
[Res. Microbiol. 152(10) , 849-59, (2001)]
1984-01-01
[Drug Metab. Dispos. 12(4) , 421-6, (1984)]